AffaMed Therapeutics Limited
1 clinical trials · Sponsor
◉ Watch AffaMed Therapeutics Limited
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of AM712 in Patients with NAMD (NCT05345769) | AffaMed Therapeutics Limited | 2022-04-28 |
Track AffaMed Therapeutics Limited automatically
Every clearance here is in the API, with alerts when new ones post.